117 related articles for article (PubMed ID: 20694906)
1. Impediments to "T2" research: are ethics really to blame?
Lipworth W; Kerridge I
Am J Bioeth; 2010 Aug; 10(8):39-40. PubMed ID: 20694906
[No Abstract] [Full Text] [Related]
2. The diverse ethics of translational research.
Sofaer N; Eyal N
Am J Bioeth; 2010 Aug; 10(8):19-30. PubMed ID: 20694901
[TBL] [Abstract][Full Text] [Related]
3. Translational research beyond approval: a two-stage ethics review.
Sofaer N; Eyal N
Am J Bioeth; 2010 Aug; 10(8):W1-3. PubMed ID: 20694895
[No Abstract] [Full Text] [Related]
4. Post-approval translational research itself has diverse ethics.
Mukherjee J
Am J Bioeth; 2010 Aug; 10(8):43-4. PubMed ID: 20694908
[No Abstract] [Full Text] [Related]
5. Ethical analysis of translational research is more complex than distinguishing T1 from T2.
Allen B
Am J Bioeth; 2010 Aug; 10(8):33-5. PubMed ID: 20694903
[No Abstract] [Full Text] [Related]
6. Diverse ethics of translational research in the developing world.
Lang T
Am J Bioeth; 2010 Aug; 10(8):41-2. PubMed ID: 20694907
[No Abstract] [Full Text] [Related]
7. Bioethics and post-approval research in translational science.
Chen JY; Carter M
Am J Bioeth; 2010 Aug; 10(8):35-7. PubMed ID: 20694904
[No Abstract] [Full Text] [Related]
8. The ethical urgency of advancing implementation science.
Solomon MZ
Am J Bioeth; 2010 Aug; 10(8):31-2. PubMed ID: 20694902
[No Abstract] [Full Text] [Related]
9. Multicentre drug trials, ethics approval and death of patients.
Millar JA
Intern Med J; 2008 Apr; 38(4):298-9; author reply 299. PubMed ID: 18380711
[No Abstract] [Full Text] [Related]
10. Reporting of ethical review of clinical research submitted to the Journal of the American Academy of Dermatology.
Perkins AC; Choi JM; Kimball AB
J Am Acad Dermatol; 2007 Feb; 56(2):279-84. PubMed ID: 17224370
[TBL] [Abstract][Full Text] [Related]
11. Innovative care, medical research, and the ethics of informed consent.
Choi JM; Salter SA; Kimball AB
J Am Acad Dermatol; 2007 Feb; 56(2):330-2. PubMed ID: 17224375
[No Abstract] [Full Text] [Related]
12. Institutional review board use among dermatology researchers.
Adams BB; Gloster HM
J Am Acad Dermatol; 2007 Feb; 56(2):346. PubMed ID: 17224377
[No Abstract] [Full Text] [Related]
13. Vulnerable subjects and civic professionalism: would six-sigma research and research ethics consultation solve the vulnerability problem?
Marshall MF
Am J Bioeth; 2004; 4(3):54-5; discussion W32. PubMed ID: 16192141
[No Abstract] [Full Text] [Related]
14. Phase IV research: innovation in need of ethics.
van Thiel GJ; van Delden JJ
J Med Ethics; 2008 Jun; 34(6):415-6. PubMed ID: 18511610
[No Abstract] [Full Text] [Related]
15. A step toward truly protecting human subjects: reviewing the review boards.
Albrecht RR
Am J Bioeth; 2004; 4(1):54-5. PubMed ID: 15035952
[No Abstract] [Full Text] [Related]
16. [A welcome guide for evaluating medical research involving human subjects].
Borst-Eilers E
Ned Tijdschr Geneeskd; 2003 May; 147(19):898-900. PubMed ID: 12768802
[TBL] [Abstract][Full Text] [Related]
17. Research ethics. Rethinking research ethics: the case of postmarketing trials.
London AJ; Kimmelman J; Carlisle B
Science; 2012 May; 336(6081):544-5. PubMed ID: 22556237
[TBL] [Abstract][Full Text] [Related]
18. Justice and research design: the case for a semi-randomization clinical trial.
Veatch RM
Clin Res; 1983 Feb; 31(1):12-22. PubMed ID: 10299203
[No Abstract] [Full Text] [Related]
19. Why I signed, and why I would do it again.
Kraft RE
Am J Bioeth; 2010 Sep; 10(9):62-3. PubMed ID: 20818567
[No Abstract] [Full Text] [Related]
20. Making pragmatism practicable for the institutional review board.
Robertson C
Am J Bioeth; 2008 Apr; 8(4):49-51. PubMed ID: 18576258
[No Abstract] [Full Text] [Related]
[Next] [New Search]
